DE69721242T2 - Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen - Google Patents

Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen Download PDF

Info

Publication number
DE69721242T2
DE69721242T2 DE69721242T DE69721242T DE69721242T2 DE 69721242 T2 DE69721242 T2 DE 69721242T2 DE 69721242 T DE69721242 T DE 69721242T DE 69721242 T DE69721242 T DE 69721242T DE 69721242 T2 DE69721242 T2 DE 69721242T2
Authority
DE
Germany
Prior art keywords
influenza virus
compounds
detecting influenza
detecting
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721242T
Other languages
German (de)
English (en)
Other versions
DE69721242D1 (de
Inventor
A Reece
Wen-Yang Wu
Betty Jin
Y Krippner
Geoffrey Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN8397A external-priority patent/AUPN839796A0/en
Priority claimed from AUPO2131A external-priority patent/AUPO213196A0/en
Priority claimed from AUPO3631A external-priority patent/AUPO363196A0/en
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Application granted granted Critical
Publication of DE69721242D1 publication Critical patent/DE69721242D1/de
Publication of DE69721242T2 publication Critical patent/DE69721242T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69721242T 1996-03-01 1997-02-26 Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen Expired - Lifetime DE69721242T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN8397A AUPN839796A0 (en) 1996-03-01 1996-03-01 Method and novel compounds for use therein
AUPO2131A AUPO213196A0 (en) 1996-09-04 1996-09-04 Method and novel compounds for use therein
AUPO3631A AUPO363196A0 (en) 1996-11-14 1996-11-14 Method and novel compounds for use therein
PCT/AU1997/000109 WO1997032214A1 (en) 1996-03-01 1997-02-26 Method of detection of influenza virus and compounds for use therein

Publications (2)

Publication Number Publication Date
DE69721242D1 DE69721242D1 (de) 2003-05-28
DE69721242T2 true DE69721242T2 (de) 2004-01-29

Family

ID=27157905

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721242T Expired - Lifetime DE69721242T2 (de) 1996-03-01 1997-02-26 Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen

Country Status (13)

Country Link
US (2) US6242582B1 (cg-RX-API-DMAC7.html)
EP (1) EP0885391B1 (cg-RX-API-DMAC7.html)
JP (1) JP3753740B2 (cg-RX-API-DMAC7.html)
KR (1) KR19990087449A (cg-RX-API-DMAC7.html)
AT (1) ATE238552T1 (cg-RX-API-DMAC7.html)
CA (1) CA2245680C (cg-RX-API-DMAC7.html)
DE (1) DE69721242T2 (cg-RX-API-DMAC7.html)
ES (1) ES2197330T3 (cg-RX-API-DMAC7.html)
HU (1) HU223099B1 (cg-RX-API-DMAC7.html)
IL (1) IL125662A0 (cg-RX-API-DMAC7.html)
NO (1) NO326042B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ331189A (cg-RX-API-DMAC7.html)
WO (1) WO1997032214A1 (cg-RX-API-DMAC7.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4153040B2 (ja) * 1996-04-02 2008-09-17 バイエル・アクチエンゲゼルシヤフト 有害生物防除剤及び除草剤としての置換されたフェニルケトエノール
JP3209946B2 (ja) 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
JP3691075B2 (ja) 1996-11-14 2005-08-31 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド 新規化合物およびその使用方法
AU1927899A (en) * 1997-12-18 1999-07-05 Sepracor, Inc. Screening assays for the detection and diagnosis of influenza virus
JP3233392B2 (ja) 1998-01-22 2001-11-26 三共株式会社 ノイラミン酸誘導体を含有する抗インフルエンザ薬
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
AU1520300A (en) * 1998-11-05 2000-05-29 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
AUPP913999A0 (en) 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US7230114B2 (en) 2001-09-07 2007-06-12 Biota Scientific Management Pty Ltd Intermediates for preparing neuraminidase inhibitor conjugates
DK1451182T3 (da) * 2001-11-09 2008-10-27 Biota Scient Management Dimere forbindelser og deres anvendelse som antivirale midler
AUPR879501A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879601A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879701A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
AUPR879401A0 (en) * 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
KR101392106B1 (ko) 2005-05-09 2014-05-07 테라노스, 인코포레이티드 현장진료 유체 시스템 및 그 용도
US8741230B2 (en) 2006-03-24 2014-06-03 Theranos, Inc. Systems and methods of sample processing and fluid control in a fluidic system
US11287421B2 (en) 2006-03-24 2022-03-29 Labrador Diagnostics Llc Systems and methods of sample processing and fluid control in a fluidic system
US8007999B2 (en) 2006-05-10 2011-08-30 Theranos, Inc. Real-time detection of influenza virus
SG188908A1 (en) 2006-07-14 2013-04-30 Wisconsin Alumni Res Found Adsorptive membranes for trapping viruses
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US20080113391A1 (en) * 2006-11-14 2008-05-15 Ian Gibbons Detection and quantification of analytes in bodily fluids
GB0702183D0 (en) * 2007-02-05 2007-03-14 Iti Scotland Ltd Pathogen binding
TWI417297B (zh) 2007-04-11 2013-12-01 Daiichi Sankyo Co Ltd 神經胺酸衍生物及其製造方法
US8158430B1 (en) 2007-08-06 2012-04-17 Theranos, Inc. Systems and methods of fluidic sample processing
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
EP2772267B1 (en) * 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
AU2008343745B2 (en) 2007-10-01 2012-05-10 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
CN105740641A (zh) * 2009-10-19 2016-07-06 提拉诺斯公司 集成的健康数据采集和分析系统
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011143262A2 (en) 2010-05-10 2011-11-17 Sinica, Academia Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
CA3207612A1 (en) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
JP6280868B2 (ja) * 2012-10-05 2018-02-14 デンカ生研株式会社 インフルエンザウイルスのヘムアグルチニンの測定方法
EP3041484B1 (en) 2013-09-06 2021-03-03 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102512592B1 (ko) 2014-05-27 2023-03-21 아카데미아 시니카 항-ｈｅｒ2 글리코항체 및 이의 용도
CZ2014527A3 (cs) 2014-08-05 2016-02-17 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Způsob detekce aktivní formy analytů ve vzorku a stanovení schopnosti dalších látek vázat se do aktivních míst těchto analytů
WO2016183292A1 (en) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Rapid methods for the extraction of nucleic acids from biological samples
TW201808978A (zh) 2016-03-08 2018-03-16 中央研究院 N-聚醣及其陣列之模組化合成方法
CN108003065B (zh) * 2016-10-27 2021-01-08 中国石油化工股份有限公司 一种具有增稠作用的化合物和润滑脂以及它们的制备方法
KR102752322B1 (ko) 2023-09-20 2025-01-09 거제대학교산학협력단 단열 기능을 가진 립스틱 용기

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450877A1 (fr) 1979-03-06 1980-10-03 Inst Nat Sante Rech Med Nouveaux tests par agglutination pour la detection des virus de la grippe, et reactifs pour la realisation de ces tests
WO1991009975A1 (en) * 1989-12-29 1991-07-11 Symex Corp. Chromogenic 7- or 8-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
DK0507854T3 (da) 1989-12-29 1997-05-12 Oklahoma Med Res Found Fremgangsmåder til diagnosticering af human-influenza og chromogene N-acetylneuraminsyresubstrater, der er modificerede i 4-positionen, til anvendelse deri
AU7176191A (en) * 1990-01-05 1991-07-24 Symex Corp. Chromogenic 5-position modified neuraminic acid substrates and methods for diagnosing human influenza therewith
AU7150891A (en) * 1990-01-10 1991-08-05 Symex Corp. Chromogenic 9-position modified n-acetylneuraminic acid substrates and methods for diagnosing human influenza therewith
SK282950B6 (sk) * 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
WO1992006691A1 (en) 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
AU656162B2 (en) * 1990-12-31 1995-01-27 Symex Corp. Method for visually detecting the presence of a virus in a clinical specimen
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
EP0881227A1 (en) * 1996-10-22 1998-12-02 Daikin Industries, Limited Gangliosides having fluorescent-tagged ceramide moieties

Also Published As

Publication number Publication date
HUP9901679A3 (en) 2000-06-28
CA2245680C (en) 2005-09-27
EP0885391B1 (en) 2003-04-23
EP0885391A4 (en) 2001-07-25
ES2197330T3 (es) 2004-01-01
ATE238552T1 (de) 2003-05-15
JP3753740B2 (ja) 2006-03-08
JP2000506008A (ja) 2000-05-23
NO984004L (no) 1998-11-02
IL125662A0 (en) 1999-04-11
NO326042B1 (no) 2008-09-08
US20020055094A1 (en) 2002-05-09
CA2245680A1 (en) 1997-09-04
HU223099B1 (hu) 2004-03-29
KR19990087449A (ko) 1999-12-27
NO984004D0 (no) 1998-08-31
HUP9901679A2 (hu) 1999-09-28
WO1997032214A1 (en) 1997-09-04
US6242582B1 (en) 2001-06-05
EP0885391A1 (en) 1998-12-23
NZ331189A (en) 1999-06-29
DE69721242D1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
DE69721242D1 (de) Verfahren zum nachweis von influenza-virus und dazu verwendbare verbindungen
AP9901531A0 (en) Method and novel compounds for use therein.
ATE498838T1 (de) Elektronische verfahren und vorrichtung zum nachweis von analyten
CY1121151T1 (el) Αντισωματα ως προς opgl
ATE360884T1 (de) Vorrichtung zum behandeln eines scheibenförmigen gegenstandes
EP1575414A4 (en) METHODS AND DEVICES FOR DETECTION AND THERAPY OF ATHEROMOUS PLAQUES
BR0009721A (pt) Inibidores de tirosina quinase de proteìna cìclica
ATE341142T1 (de) System und verfahren zur ausführung einer gegen crawler angriff geschützten web-seite
ATE220797T1 (de) Verbindungen und verfahren zum nachweis von t. cruzi-infektion
DE60334664D1 (de) System und Verfahren zum Nachweis von biologischem und chemischem Material
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE60324994D1 (de) Verfahren und Vorrichtung zur Verhinderung der Ausbreitung von böswilligen Programmkode
NO20004935L (no) Anordning til den transdermale avleveringen av diklofenak
ATE404587T1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
DK0817622T3 (da) Transdermalt applicerbart lægemiddel med ACE-hæmmere
DE60137346D1 (de) Rechnerverfahren und -system zum ausführen von java-rechnerprogrammen
ATE234884T1 (de) Carboxylfunktionelles additiv zur aufkondensierung von polyamiden
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE60105025D1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
ATE269529T1 (de) Verfahren zur behandlung von abgasen in der stahlindustrie
DE502004011851D1 (de) Caspase 3, 8, 9 oder 10 Inhibitoren in Kombination mit MEK Inhibitoren zur Behandlung von Influenza
DE50103764D1 (de) Salze von bicyclischen, n-acylierten imidazo-3-aminen und imidazo-5-aminen
DE50115254D1 (de) Verfahren zum erkennen und/oder begrenzen von kurzndler
ATE255594T1 (de) Hepatitis b inhibitoren
PT1019032E (pt) Processo para evitar a ma utilizacao de um sistema terapeutico transdermico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition